Esperion Therapeutics, Inc.ESPRNASDAQ
LOADING
|||
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
5.98%
↓ 98% below average
Average (39q)
304.62%
Historical baseline
Range
High:11434.57%
Low:-99.32%
Volatility
3786.3%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 5.98% |
| Q2 2025 | 26.76% |
| Q1 2025 | -5.96% |
| Q4 2024 | 33.86% |
| Q3 2024 | -30.07% |
| Q2 2024 | -46.39% |
| Q1 2024 | 327.09% |
| Q4 2023 | -5.06% |
| Q3 2023 | 31.73% |
| Q2 2023 | 5.99% |
| Q1 2023 | 29.29% |
| Q4 2022 | -0.85% |
| Q3 2022 | 0.74% |
| Q2 2022 | 0.03% |
| Q1 2022 | 22.30% |
| Q4 2021 | 6.88% |
| Q3 2021 | -64.56% |
| Q2 2021 | 409.64% |
| Q1 2021 | -17.22% |
| Q4 2020 | 151.45% |
| Q3 2020 | -98.19% |
| Q2 2020 | 11434.57% |
| Q1 2020 | 87.37% |
| Q4 2019 | 0.10% |
| Q3 2019 | -0.10% |
| Q2 2019 | -99.32% |
| Q1 2019 | -21.17% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |